Effect of Mirror Therapy on the Arteriovenous Fistula Cannulation-related Pain and Anxiety
CompletedNot applicableNCT06683495
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Pharmacological and non-pharmacological methods are frequently used to reduce cannulation-related pain in patients with fistulas. Non-pharmacological approaches have been more favored than pharmacological approaches for some reasons, including ease of use and fewer side effects. Patients describe worry about the success of needling and resigned acceptance of pain and anxiety about dialysis needles. With this background in mind, mirror therapy has been introduced as one of the non-pharmacological interventions in the domain of pain management.
Study details
- Official title
- Effect of Mirror Therapy on the Arteriovenous Fistula Cannulation-related Pain and Anxiety: A Prospective, Single Blind Randomized Controlled Study
- Conditions
- Pain, Chronic
- Fistula
- Hemodialysis Complication
- Interventions
- Other: Mirror Therapy
- Sponsor
- Istanbul University
- Start date
- 2025-01-05
- Primary completion
- 2025-04-05
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients aged 18 years and older * Patients who received hemodialysis (HD) treatment with an arteriovenous fistula (AVF) for at least 3 months * Patients receiving HD treatment 3 days a week for 4 hours each session * Patients with a pain score of ⩾1 during AVF cannulation, measured by a visual analog scale (VAS) * Patients able to communicate in Turkish * Patients without psychiatric disorders that impair communication * Patients who agreed to participate in the study Exclusion Criteria: * Patients who were known to present difficulties with fistula cannulation (requiring multiple cannulations) * Patients with a history of hematoma or stenosis in the arteriovenous fistula (AVF) * Patients with an infection at the fistula site * Patients who took painkillers within 3 hours prior to treatment * Patients unable to maintain a sitting position on the bed * Patients with low vision or visual disturbances (30 cm or less) * Patients who did not wish to participate in the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06683495